Advertisement

Health


Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane biotech to trial "world-first" COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics plans major expansion of Tasmanian cannabis farm

ECS Botanics (ASX: ECS) has submitted plans to the Office of Drug...

Creso Pharma appoints director of US business after New York legalises marijuana

Creso Pharma appoints director of US business after New York legalises marijuana

Australian medicinal cannabis company Creso Pharma (ASX: CPH) has...

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Cynata COVID-19 treatment trial expanded to other respiratory illnesses

Stem cell therapeutics company Cynata's (ASX: CYP) pool of el...

Advertisement
Advertisement
Advertisement
Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Starpharma to launch anti-COVID nasal spray with major UK pharmacy chain

Pharmaceuticals manufacturer Starpharma (ASX: SPL) will commence ...

New US trial finds AstraZeneca vaccine 79 per cent effective

New US trial finds AstraZeneca vaccine 79 per cent effective

A Phase III trial of the AstraZeneca vaccine in the US has demons...

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Openpay cracks into US and UK veterinary markets with ezyVet partnership

Buy-now pay-later (BNPL) operator Openpay (ASX: OPY) has announce...

IDT looks to manufacture COVID-19 vaccines on-shore

IDT looks to manufacture COVID-19 vaccines on-shore

Victorian pharmaceuticals manufacturer IDT Australia (ASX: IDT) h...

Centuria to build Melbourne hospital for doctor-led Medicare JV

Centuria to build Melbourne hospital for doctor-led Medicare JV

A subsidiary of Centuria Capital Group (ASX: CNI) has entered a p...

People Infrastructure acquires SwingShift Nurses

People Infrastructure acquires SwingShift Nurses

Workforce management company People Infrastructure (ASX: PPE) con...

Elixinol to bag German CBD brand for $13.9m

Elixinol to bag German CBD brand for $13.9m

Australian cannabis company Elixinol's (ASX: EXL) plans to pu...

Creso Pharma expanding into psychedelics with planned acquisition

Creso Pharma expanding into psychedelics with planned acquisition

Creso Pharma (ASX: CPH) is looking to tap into the emerging psych...

Mesoblast receives $138m injection from US investors

Mesoblast receives $138m injection from US investors

Australian biotechnology company Mesoblast (ASX: MSB) will receiv...

Investors like what they see under Healthia's skin, boosting its value to $185m

Investors like what they see under Healthia's skin, boosting its value to $185m

Allied health company Healthia Limited (ASX: HLA) has almost doub...

Needle-phobes rejoice: NeedleCalm launches in Australia

Needle-phobes rejoice: NeedleCalm launches in Australia

An innovative piece of medical technology aimed at reducing physi...

Medibank profit rises, CEO Craig Drummond to depart

Medibank profit rises, CEO Craig Drummond to depart

Private health insurance provider Medibank (ASX: MPL) has capital...

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Australian pharmaceutical company Starpharma's (ASX: SPL) ant...

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Mitigation measures against COVID-19 led to a drastic reduction i...

Profits double for IVF specialist Virtus Health

Profits double for IVF specialist Virtus Health

As the leading assisted reproductive services (ARS) company ...

Advertisement

Partner Content

Whilst some cannabis stocks can trade on hype and future earnings...
The focus on digital health has become a global trend. The long...
Food Revolution Group (ASX: FOD) could be the ASX's turnaroun...
A big shift in consumer spending habits over the past year has pl...
It took determination and ambition for Glen Richards to scale up ...
It's fair to say that at the start of 2020, few would have pr...
Momentum for cannabis stocks continues to intensify, as internati...
ESG (Environment, Social, Governance) has become essential in bus...
While some prefer to invest their money in stocks, bonds or prope...
If intellectual property (IP) is what differentiates a business f...
Advertisement